Jupiter Life Line Hospitals Ltd
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
- Market Cap ₹ 7,935 Cr.
- Current Price ₹ 1,210
- High / Low ₹ 1,654 / 960
- Stock P/E 57.2
- Book Value ₹ 177
- Dividend Yield 0.00 %
- ROCE 26.7 %
- ROE 27.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 29.4% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|
320 | 398 | 463 | 461 | 657 | 787 | 876 | |
266 | 333 | 380 | 392 | 498 | 583 | 657 | |
Operating Profit | 54 | 65 | 83 | 69 | 159 | 204 | 219 |
OPM % | 17% | 16% | 18% | 15% | 24% | 26% | 25% |
5 | 2 | 2 | 4 | 4 | 11 | 23 | |
Interest | 16 | 24 | 26 | 28 | 29 | 28 | 25 |
Depreciation | 20 | 24 | 26 | 27 | 28 | 29 | 30 |
Profit before tax | 24 | 20 | 33 | 18 | 106 | 159 | 187 |
Tax % | -25% | 8% | 10% | 5% | 20% | 33% | |
30 | 18 | 30 | 17 | 85 | 107 | 136 | |
EPS in Rs | 5.88 | 3.57 | 5.83 | 3.26 | 16.65 | 18.97 | 22.07 |
Dividend Payout % | 8% | -0% | -0% | -0% | -0% | -0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 19% |
TTM: | 20% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 29% |
3 Years: | 54% |
TTM: | 28% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | 23% |
Last Year: | 27% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|
Equity Capital | 51 | 51 | 51 | 51 | 51 | 57 | 66 |
Reserves | 147 | 162 | 186 | 202 | 276 | 409 | 1,095 |
210 | 252 | 263 | 262 | 322 | 298 | -0 | |
63 | 71 | 94 | 100 | 106 | 123 | 146 | |
Total Liabilities | 470 | 537 | 594 | 615 | 755 | 885 | 1,306 |
379 | 431 | 435 | 426 | 465 | 476 | 474 | |
CWIP | 28 | 12 | 10 | 13 | 14 | 16 | 25 |
Investments | 1 | 2 | 2 | 65 | 71 | 95 | 95 |
63 | 92 | 146 | 109 | 205 | 297 | 712 | |
Total Assets | 470 | 537 | 594 | 615 | 755 | 885 | 1,306 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
43 | 46 | 75 | 113 | 142 | 183 | |
-43 | -58 | -43 | -78 | -68 | -59 | |
1 | 16 | -32 | -23 | 10 | -93 | |
Net Cash Flow | 1 | 3 | -1 | 12 | 84 | 31 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
Debtor Days | 20 | 24 | 35 | 16 | 15 | 19 |
Inventory Days | 60 | 46 | 64 | 45 | 38 | 42 |
Days Payable | 224 | 168 | 268 | 192 | 155 | 169 |
Cash Conversion Cycle | -144 | -98 | -169 | -132 | -101 | -108 |
Working Capital Days | 11 | 18 | 44 | 4 | -4 | -16 |
ROCE % | 10% | 12% | 9% | 23% | 27% |
Documents
Announcements
-
Compliance - Regulation 40(9) Of SEBI (LODR) Regulation, 2015
10 Apr - Certificate received from Practicing Company Secretary as required under Regulation 40 (9) of SEBI (LODR) Regulations, 2015
-
Compliance Certificate For The Year Ended March 31, 2024
6 Apr - Compliance certificate duly signed by the Compliance Officer of the Company and the authorized representative of the share transfer agent.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Apr - In Compliance with Reg 74(5) of SEBI (DP) Regulations, 2018, Please find attached certificate received from M/s. KFin Technologies Limited.
- Closure of Trading Window 28 Mar
-
Announcement under Regulation 30 (LODR)-Credit Rating
27 Mar - ICRA Limited has assigned the ratings on bank facilities availed by the Company. The rating letter of ICRA is enclosed in the attachment.
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Oct 2023TranscriptNotesPPT
Business Profile[1] The company has been operating for over 15 years as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. They operate 1194 beds, and have 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023.